Novo Nordisk logo

Sourcing Director, China External Innovation

Novo Nordisk
June 26, 2026
Remote friendly (Shanghai, VA)
United States
Corporate Functions
Role purpose
- Originating, evaluating, and driving biotech collaboration deals that create pipeline value through biotech partnership and co-development.

Responsibilities
- Coordinate structured gap analysis with internal stakeholders (Therapeutic Areas, Target Discovery, Medicinal Chemistry, Computational Chemistry, and other functions) to identify biology/chemistry/capability/capacity gaps.
- Translate gaps into sourcing hypotheses and partnership requirements; proactively source and triage biotech opportunities across China based on the gap analysis.
- Lead deep scientific evaluation, including:
- Medicinal Chemistry quality and design hypotheses
- CADD/AIDD drug design maturity and real-world impact
- Translational relevance and execution risk
- Drive opportunities through EI pipeline-filling processes: internal alignment and framing; pre-due diligence/due diligence input; preparation of decision materials for EI and LoB forums.
- Shape the scientific and structural aspects of deals, partnering with alliance management and BD on contracting and execution.
- Ensure collaborations align with global pipeline needs; enable smooth handover and absorption of externally generated assets into NN programs.

Qualifications
- PhD in Medicinal Chemistry, Computational Chemistry, Life Sciences, or related discipline.
- 8+ years’ experience in: small-molecule drug development; biotech collaborations/external innovation; Medicinal Chemistry and CADD/AIDD-enabled programs.
- Demonstrated experience evaluating and advancing deals involving early biotech pipelines and platform-based drug development collaborations.
- Strong ability to assess chemistry-driven programs and AI-enabled design claims with scientific rigor.
- Motivated, proactive, able to influence without authority, and comfortable in ambiguity.

Working conditions
- Based in Shanghai; up to ~20% travel (primarily within China).